EMEA (Europe, Middle East and Africa) Oral Contraceptive Market Report 2017

August 2017 | 103 pages | ID: E1DEC8576DDEN
QYResearch

Abstracts

In this report, the EMEA Oral Contraceptive market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Doses), revenue (Million USD), market share and growth rate of Oral Contraceptive for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Oral Contraceptive market competition by top manufacturers/players, with Oral Contraceptive sales volume (K Doses), price (USD/Dose), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Pfizer, Inc.
• Bayer AG
• Merck & Co., Inc.
• Janssen Global Services, LLC
• Mankind Pharma Ltd.
• Teva Pharmaceutical Industries Ltd
• Allergan, plc (Actavis)
• Piramal Enterprises Ltd.
• Beijing Zizhu Pharm

On the basis of product, this report displays the sales volume (K Doses), revenue (Million USD), product price (USD/Dose), market share and growth rate of each type, primarily split into

• Combination
• Progestin Only
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Doses), market share and growth rate of Oral Contraceptive for each application, including

• Male
• Female

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Oral Contraceptive Market Report 2017

1 ORAL CONTRACEPTIVE OVERVIEW

1.1 Product Overview and Scope of Oral Contraceptive
1.2 Classification of Oral Contraceptive
  1.2.1 EMEA Oral Contraceptive Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Oral Contraceptive Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Combination
  1.2.4 Progestin Only
  1.2.5 Others
1.3 EMEA Oral Contraceptive Market by Application/End Users
  1.3.1 EMEA Oral Contraceptive Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Male
  1.3.3 Female
1.4 EMEA Oral Contraceptive Market by Region
  1.4.1 EMEA Oral Contraceptive Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Oral Contraceptive (2012-2022)
  1.5.1 EMEA Oral Contraceptive Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Oral Contraceptive Revenue and Growth Rate (2012-2022)

2 EMEA ORAL CONTRACEPTIVE COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Oral Contraceptive Market Competition by Players/Manufacturers
  2.1.1 EMEA Oral Contraceptive Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Oral Contraceptive Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Oral Contraceptive Sale Price by Players (2012-2017)
2.2 EMEA Oral Contraceptive (Volume and Value) by Type/Product Category
  2.2.1 EMEA Oral Contraceptive Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Oral Contraceptive Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Oral Contraceptive Sale Price by Type (2012-2017)
2.3 EMEA Oral Contraceptive (Volume) by Application
2.4 EMEA Oral Contraceptive (Volume and Value) by Region
  2.4.1 EMEA Oral Contraceptive Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Oral Contraceptive Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Oral Contraceptive Sales Price by Region (2012-2017)

3 EUROPE ORAL CONTRACEPTIVE (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Oral Contraceptive Sales and Value (2012-2017)
  3.1.1 Europe Oral Contraceptive Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Oral Contraceptive Revenue and Growth Rate (2012-2017)
3.2 Europe Oral Contraceptive Sales and Market Share by Type
3.3 Europe Oral Contraceptive Sales and Market Share by Application
3.4 Europe Oral Contraceptive Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Oral Contraceptive Sales Volume by Countries (2012-2017)
  3.4.2 Europe Oral Contraceptive Revenue by Countries (2012-2017)
  3.4.3 Germany Oral Contraceptive Sales and Growth Rate (2012-2017)
  3.4.4 France Oral Contraceptive Sales and Growth Rate (2012-2017)
  3.4.5 UK Oral Contraceptive Sales and Growth Rate (2012-2017)
  3.4.6 Russia Oral Contraceptive Sales and Growth Rate (2012-2017)
  3.4.7 Italy Oral Contraceptive Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Oral Contraceptive Sales and Growth Rate (2012-2017)

4 MIDDLE EAST ORAL CONTRACEPTIVE (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Oral Contraceptive Sales and Value (2012-2017)
  4.1.1 Middle East Oral Contraceptive Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Oral Contraceptive Revenue and Growth Rate (2012-2017)
4.2 Middle East Oral Contraceptive Sales and Market Share by Type
4.3 Middle East Oral Contraceptive Sales and Market Share by Application
4.4 Middle East Oral Contraceptive Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Oral Contraceptive Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Oral Contraceptive Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Oral Contraceptive Sales and Growth Rate (2012-2017)
  4.4.4 Israel Oral Contraceptive Sales and Growth Rate (2012-2017)
  4.4.5 UAE Oral Contraceptive Sales and Growth Rate (2012-2017)
  4.4.6 Iran Oral Contraceptive Sales and Growth Rate (2012-2017)

5 AFRICA ORAL CONTRACEPTIVE (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Oral Contraceptive Sales and Value (2012-2017)
  5.1.1 Africa Oral Contraceptive Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Oral Contraceptive Revenue and Growth Rate (2012-2017)
5.2 Africa Oral Contraceptive Sales and Market Share by Type
5.3 Africa Oral Contraceptive Sales and Market Share by Application
5.4 Africa Oral Contraceptive Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Oral Contraceptive Sales Volume by Countries (2012-2017)
  5.4.2 Africa Oral Contraceptive Revenue by Countries (2012-2017)
  5.4.3 South Africa Oral Contraceptive Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Oral Contraceptive Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Oral Contraceptive Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Oral Contraceptive Sales and Growth Rate (2012-2017)

6 EMEA ORAL CONTRACEPTIVE MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Pfizer, Inc.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Oral Contraceptive Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Pfizer, Inc. Oral Contraceptive Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Bayer AG
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Oral Contraceptive Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Bayer AG Oral Contraceptive Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Merck & Co., Inc.
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Oral Contraceptive Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Merck & Co., Inc. Oral Contraceptive Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Janssen Global Services, LLC
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Oral Contraceptive Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Janssen Global Services, LLC Oral Contraceptive Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Mankind Pharma Ltd.
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Oral Contraceptive Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Mankind Pharma Ltd. Oral Contraceptive Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Teva Pharmaceutical Industries Ltd
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Oral Contraceptive Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Teva Pharmaceutical Industries Ltd Oral Contraceptive Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Allergan, plc (Actavis)
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Oral Contraceptive Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Allergan, plc (Actavis) Oral Contraceptive Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Piramal Enterprises Ltd.
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Oral Contraceptive Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Piramal Enterprises Ltd. Oral Contraceptive Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Beijing Zizhu Pharm
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Oral Contraceptive Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Beijing Zizhu Pharm Oral Contraceptive Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview

7 ORAL CONTRACEPTIVE MANUFACTURING COST ANALYSIS

7.1 Oral Contraceptive Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Oral Contraceptive

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Oral Contraceptive Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Oral Contraceptive Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA ORAL CONTRACEPTIVE MARKET FORECAST (2017-2022)

11.1 EMEA Oral Contraceptive Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Oral Contraceptive Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Oral Contraceptive Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Oral Contraceptive Price and Trend Forecast (2017-2022)
11.2 EMEA Oral Contraceptive Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Oral Contraceptive Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Oral Contraceptive Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Oral Contraceptive Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Oral Contraceptive Sales Forecast by Type (2017-2022)
11.7 EMEA Oral Contraceptive Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Oral Contraceptive
Figure EMEA Oral Contraceptive Sales Volume (K Doses) by Type (2012-2022)
Figure EMEA Oral Contraceptive Sales Volume Market Share by Type (Product Category) in 2016
Figure Combination Product Picture
Figure Progestin Only Product Picture
Figure Others Product Picture
Figure EMEA Oral Contraceptive Sales Volume (K Doses) by Application (2012-2022)
Figure EMEA Sales Market Share of Oral Contraceptive by Application in 2016
Figure Male Examples
Table Key Downstream Customer in Male
Figure Female Examples
Table Key Downstream Customer in Female
Figure EMEA Oral Contraceptive Market Size (Million USD) by Region (2012-2022)
Figure Europe Oral Contraceptive Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Oral Contraceptive Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Oral Contraceptive Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Oral Contraceptive Revenue (Million USD) Status and Forecast by Countries
Figure Africa Oral Contraceptive Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Oral Contraceptive Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Oral Contraceptive Sales Volume and Growth Rate (2012-2022)
Figure EMEA Oral Contraceptive Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Oral Contraceptive Market Major Players Product Sales Volume (K Doses) (2012-2017)
Table EMEA Oral Contraceptive Sales Volume (K Doses) of Major Players (2012-2017)
Table EMEA Oral Contraceptive Sales Share by Players (2012-2017)
Figure 2016 Oral Contraceptive Sales Share by Players
Figure 2017 Oral Contraceptive Sales Share by Players
Figure EMEA Oral Contraceptive Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Oral Contraceptive Revenue (Million USD) by Players (2012-2017)
Table EMEA Oral Contraceptive Revenue Share by Players (2012-2017)
Table 2016 EMEA Oral Contraceptive Revenue Share by Players
Table 2017 EMEA Oral Contraceptive Revenue Share by Players
Table EMEA Oral Contraceptive Sale Price (USD/Dose) by Players (2012-2017)
Table EMEA Oral Contraceptive Sales (K Doses) and Market Share by Type (2012-2017)
Table EMEA Oral Contraceptive Sales Share by Type (2012-2017)
Figure Sales Market Share of Oral Contraceptive by Type (2012-2017)
Figure EMEA Oral Contraceptive Sales Market Share by Type (2012-2017)
Table EMEA Oral Contraceptive Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Oral Contraceptive Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Oral Contraceptive by Type in 2016
Table EMEA Oral Contraceptive Sale Price (USD/Dose) by Type (2012-2017)
Table EMEA Oral Contraceptive Sales (K Doses) and Market Share by Application (2012-2017)
Table EMEA Oral Contraceptive Sales Share by Application (2012-2017)
Figure Sales Market Share of Oral Contraceptive by Application (2012-2017)
Figure EMEA Oral Contraceptive Sales Market Share by Application in 2016
Table EMEA Oral Contraceptive Sales (K Doses) and Market Share by Region (2012-2017)
Table EMEA Oral Contraceptive Sales Share by Region (2012-2017)
Figure Sales Market Share of Oral Contraceptive by Region (2012-2017)
Figure EMEA Oral Contraceptive Sales Market Share in 2016
Table EMEA Oral Contraceptive Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Oral Contraceptive Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Oral Contraceptive by Region (2012-2017)
Figure EMEA Oral Contraceptive Revenue Market Share Regions in 2016
Table EMEA Oral Contraceptive Sales Price (USD/Dose) by Region (2012-2017)
Figure Europe Oral Contraceptive Sales (K Doses) and Growth Rate (2012-2017)
Figure Europe Oral Contraceptive Revenue and Growth Rate (2012-2017)
Table Europe Oral Contraceptive Sales (K Doses) by Type (2012-2017)
Table Europe Oral Contraceptive Market Share by Type (2012-2017)
Figure Europe Oral Contraceptive Market Share by Type in 2016
Table Europe Oral Contraceptive Sales (K Doses) by Application (2012-2017)
Table Europe Oral Contraceptive Market Share by Application (2012-2017)
Figure Europe Oral Contraceptive Market Share by Application in 2016
Table Europe Oral Contraceptive Sales (K Doses) by Countries (2012-2017)
Table Europe Oral Contraceptive Sales Market Share by Countries (2012-2017)
Figure Europe Oral Contraceptive Sales Market Share by Countries (2012-2017)
Figure Europe Oral Contraceptive Sales Market Share by Countries in 2016
Table Europe Oral Contraceptive Revenue (Million USD) by Countries (2012-2017)
Table Europe Oral Contraceptive Revenue Market Share by Countries (2012-2017)
Figure Europe Oral Contraceptive Revenue Market Share by Countries (2012-2017)
Figure Europe Oral Contraceptive Revenue Market Share by Countries in 2016
Figure Germany Oral Contraceptive Sales (K Doses) and Growth Rate (2012-2017)
Figure France Oral Contraceptive Sales (K Doses) and Growth Rate (2012-2017)
Figure UK Oral Contraceptive Sales (K Doses) and Growth Rate (2012-2017)
Figure Russia Oral Contraceptive Sales (K Doses) and Growth Rate (2012-2017)
Figure Italy Oral Contraceptive Sales (K Doses) and Growth Rate (2012-2017)
Figure Benelux Oral Contraceptive Sales (K Doses) and Growth Rate (2012-2017)
Figure Middle East Oral Contraceptive Sales (K Doses) and Growth Rate (2012-2017)
Figure Middle East Oral Contraceptive Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Oral Contraceptive Sales (K Doses) by Type (2012-2017)
Table Middle East Oral Contraceptive Market Share by Type (2012-2017)
Figure Middle East Oral Contraceptive Market Share by Type (2012-2017)
Table Middle East Oral Contraceptive Sales (K Doses) by Applications (2012-2017)
Table Middle East Oral Contraceptive Market Share by Applications (2012-2017)
Figure Middle East Oral Contraceptive Sales Market Share by Application in 2016
Table Middle East Oral Contraceptive Sales Volume (K Doses) by Countries (2012-2017)
Table Middle East Oral Contraceptive Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Oral Contraceptive Sales Volume Market Share by Countries in 2016
Table Middle East Oral Contraceptive Revenue (Million USD) by Countries (2012-2017)
Table Middle East Oral Contraceptive Revenue Market Share by Countries (2012-2017)
Figure Middle East Oral Contraceptive Revenue Market Share by Countries (2012-2017)
Figure Middle East Oral Contraceptive Revenue Market Share by Countries in 2016
Figure Saudi Arabia Oral Contraceptive Sales (K Doses) and Growth Rate (2012-2017)
Figure Israel Oral Contraceptive Sales (K Doses) and Growth Rate (2012-2017)
Figure UAE Oral Contraceptive Sales (K Doses) and Growth Rate (2012-2017)
Figure Iran Oral Contraceptive Sales (K Doses) and Growth Rate (2012-2017)
Figure Africa Oral Contraceptive Sales (K Doses) and Growth Rate (2012-2017)
Figure Africa Oral Contraceptive Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Oral Contraceptive Sales (K Doses) by Type (2012-2017)
Table Africa Oral Contraceptive Sales Market Share by Type (2012-2017)
Figure Africa Oral Contraceptive Sales Market Share by Type (2012-2017)
Figure Africa Oral Contraceptive Sales Market Share by Type in 2016
Table Africa Oral Contraceptive Sales (K Doses) by Application (2012-2017)
Table Africa Oral Contraceptive Sales Market Share by Application (2012-2017)
Figure Africa Oral Contraceptive Sales Market Share by Application (2012-2017)
Table Africa Oral Contraceptive Sales Volume (K Doses) by Countries (2012-2017)
Table Africa Oral Contraceptive Sales Market Share by Countries (2012-2017)
Figure Africa Oral Contraceptive Sales Market Share by Countries (2012-2017)
Figure Africa Oral Contraceptive Sales Market Share by Countries in 2016
Table Africa Oral Contraceptive Revenue (Million USD) by Countries (2012-2017)
Table Africa Oral Contraceptive Revenue Market Share by Countries (2012-2017)
Figure Africa Oral Contraceptive Revenue Market Share by Countries (2012-2017)
Figure Africa Oral Contraceptive Revenue Market Share by Countries in 2016
Figure South Africa Oral Contraceptive Sales (K Doses) and Growth Rate (2012-2017)
Figure Nigeria Oral Contraceptive Sales (K Doses) and Growth Rate (2012-2017)
Figure Egypt Oral Contraceptive Sales (K Doses) and Growth Rate (2012-2017)
Figure Algeria Oral Contraceptive Sales (K Doses) and Growth Rate (2012-2017)
Table Pfizer, Inc. Oral Contraceptive Basic Information List
Table Pfizer, Inc. Oral Contraceptive Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Pfizer, Inc. Oral Contraceptive Sales (K Doses) and Growth Rate (2012-2017)
Figure Pfizer, Inc. Oral Contraceptive Sales Market Share in EMEA (2012-2017)
Figure Pfizer, Inc. Oral Contraceptive Revenue Market Share in EMEA (2012-2017)
Table Bayer AG Oral Contraceptive Basic Information List
Table Bayer AG Oral Contraceptive Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Bayer AG Oral Contraceptive Sales (K Doses) and Growth Rate (2012-2017)
Figure Bayer AG Oral Contraceptive Sales Market Share in EMEA (2012-2017)
Figure Bayer AG Oral Contraceptive Revenue Market Share in EMEA (2012-2017)
Table Merck & Co., Inc. Oral Contraceptive Basic Information List
Table Merck & Co., Inc. Oral Contraceptive Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Merck & Co., Inc. Oral Contraceptive Sales (K Doses) and Growth Rate (2012-2017)
Figure Merck & Co., Inc. Oral Contraceptive Sales Market Share in EMEA (2012-2017)
Figure Merck & Co., Inc. Oral Contraceptive Revenue Market Share in EMEA (2012-2017)
Table Janssen Global Services, LLC Oral Contraceptive Basic Information List
Table Janssen Global Services, LLC Oral Contraceptive Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Janssen Global Services, LLC Oral Contraceptive Sales (K Doses) and Growth Rate (2012-2017)
Figure Janssen Global Services, LLC Oral Contraceptive Sales Market Share in EMEA (2012-2017)
Figure Janssen Global Services, LLC Oral Contraceptive Revenue Market Share in EMEA (2012-2017)
Table Mankind Pharma Ltd. Oral Contraceptive Basic Information List
Table Mankind Pharma Ltd. Oral Contraceptive Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Mankind Pharma Ltd. Oral Contraceptive Sales (K Doses) and Growth Rate (2012-2017)
Figure Mankind Pharma Ltd. Oral Contraceptive Sales Market Share in EMEA (2012-2017)
Figure Mankind Pharma Ltd. Oral Contraceptive Revenue Market Share in EMEA (2012-2017)
Table Teva Pharmaceutical Industries Ltd Oral Contraceptive Basic Information List
Table Teva Pharmaceutical Industries Ltd Oral Contraceptive Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Industries Ltd Oral Contraceptive Sales (K Doses) and Growth Rate (2012-2017)
Figure Teva Pharmaceutical Industries Ltd Oral Contraceptive Sales Market Share in EMEA (2012-2017)
Figure Teva Pharmaceutical Industries Ltd Oral Contraceptive Revenue Market Share in EMEA (2012-2017)
Table Allergan, plc (Actavis) Oral Contraceptive Basic Information List
Table Allergan, plc (Actavis) Oral Contraceptive Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Allergan, plc (Actavis) Oral Contraceptive Sales (K Doses) and Growth Rate (2012-2017)
Figure Allergan, plc (Actavis) Oral Contraceptive Sales Market Share in EMEA (2012-2017)
Figure Allergan, plc (Actavis) Oral Contraceptive Revenue Market Share in EMEA (2012-2017)
Table Piramal Enterprises Ltd. Oral Contraceptive Basic Information List
Table Piramal Enterprises Ltd. Oral Contraceptive Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Piramal Enterprises Ltd. Oral Contraceptive Sales (K Doses) and Growth Rate (2012-2017)
Figure Piramal Enterprises Ltd. Oral Contraceptive Sales Market Share in EMEA (2012-2017)
Figure Piramal Enterprises Ltd. Oral Contraceptive Revenue Market Share in EMEA (2012-2017)
Table Beijing Zizhu Pharm Oral Contraceptive Basic Information List
Table Beijing Zizhu Pharm Oral Contraceptive Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2012-2017)
Figure Beijing Zizhu Pharm Oral Contraceptive Sales (K Doses) and Growth Rate (2012-2017)
Figure Beijing Zizhu Pharm Oral Contraceptive Sales Market Share in EMEA (2012-2017)
Figure Beijing Zizhu Pharm Oral Contraceptive Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oral Contraceptive
Figure Manufacturing Process Analysis of Oral Contraceptive
Figure Oral Contraceptive Industrial Chain Analysis
Table Raw Materials Sources of Oral Contraceptive Major Manufacturers in 2016
Table Major Buyers of Oral Contraceptive
Table Distributors/Traders List
Figure EMEA Oral Contraceptive Sales (K Doses) and Growth Rate Forecast (2017-2022)
Figure EMEA Oral Contraceptive Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Oral Contraceptive Price (USD/Dose) and Trend Forecast (2017-2022)
Table EMEA Oral Contraceptive Sales (K Doses) Forecast by Region (2017-2022)
Figure EMEA Oral Contraceptive Sales Market Share Forecast by Region (2017-2022)
Table EMEA Oral Contraceptive Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Oral Contraceptive Revenue Market Share Forecast by Region (2017-2022)
Table Europe Oral Contraceptive Sales (K Doses) Forecast by Countries (2017-2022)
Figure Europe Oral Contraceptive Sales Market Share Forecast by Countries (2017-2022)
Table Europe Oral Contraceptive Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Oral Contraceptive Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Oral Contraceptive Sales (K Doses) Forecast by Countries (2017-2022)
Figure Middle East Oral Contraceptive Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Oral Contraceptive Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Oral Contraceptive Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Oral Contraceptive Sales (K Doses) Forecast by Countries (2017-2022)
Figure Africa Oral Contraceptive Sales Market Share Forecast by Countries (2017-2022)
Table Africa Oral Contraceptive Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Oral Contraceptive Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Oral Contraceptive Sales (K Doses) Forecast by Type (2017-2022)
Figure EMEA Oral Contraceptive Sales Market Share Forecast by Type (2017-2022)
Table EMEA Oral Contraceptive Sales (K Doses) Forecast by Application (2017-2022)
Figure EMEA Oral Contraceptive Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources